Sponsor or institution
Clinical trials and research at Kali Therapeutics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Kali Therapeutics, Inc. that are recruiting, at sites in 2 countries (most in Australia (2), New Zealand (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
KT502 first-in-human test in adults with rheumatoid arthritis
A first-in-human, Phase 1 study will test KT502 in adults with moderately to severely active rheumatoid arthritis to see if it is safe and tolerable.
-
First-in-human KT501 for rheumatoid arthritis
This Phase 1, open-label test will give a single under-the-skin dose of KT501 to adults with moderate to severe rheumatoid arthritis to see if it is safe and how it acts in the body.
Quick answers
How many clinical trials run by Kali Therapeutics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Australia (2 trials), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.